Net Pals Net Pals
Arama Sonuçları
Tüm Sonuçları Gör
  • Katıl
    Giriş yapın
    Başvur
    Site içinde arama yapın
    Night Mode

Site içinde arama yapın

Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek

  • Web sayfası bildirimcisi
  • EXPLORE
  • Sayfalar
  • Gruplar
  • Events
  • Reels
  • Blogs
  • Market
  • Offers
  • Jobs
  • Yazı
  • Blogs
  • Kullanıcılar
  • Sayfalar
  • Gruplar
  • Events
  • mahir007 bir ses eklendi Other
    2026-11-16 13:21:25 - Translate -
    Biotechnology Market Size, Share, Trends & Forecast 2033
    Latest Insights on Executive Summary Biotechnology Market Share and SizeCAGR Value The global biotechnology market was valued at USD 1.70 billion in 2024 and is expected to reach USD 13.03 billion by 2032 The Biotechnology Market report is the best to know the trends and opportunities in Biotechnology Market The forecast, analysis, evaluations, and estimations carried out in this...
    0 Yorumlar 0 hisse senetleri 22 Views 0 önizleme
    Please log in to like, share and comment!
  • SaadIqbal bir ses eklendi Health
    2026-10-26 15:58:11 - Translate -
    Danaher (DHR) raised its 2026 profit outlook as core sales grew only 3.0%
    Adjusted earnings per share rose 11.5% in the third quarter while core sales grew 3.0%, and the full-year range moved up by less than the quarter's gain. Cash flow and segment mix tell a narrower story. Danaher Corporation (DHR) reported third-quarter 2026 results on October 21 and raised its full-year adjusted earnings guidance. Adjusted diluted earnings per share reached $2.11, up from $1.89...
    0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
    Please log in to like, share and comment!
  • RobertMitchell bir ses eklendi Health
    2026-10-23 19:35:08 - Translate -
    Natera (NTRA) draws a Buy and a $475 target as Roth/MKM bets on cancer residual disease tests
    Roth/MKM started coverage of Natera, Inc. (NTRA) at Buy with a $475 target, pointing to wider use of its minimal residual disease blood tests, firmer pricing and a 2027 early detection study readout. Roth/MKM started coverage of Natera, Inc. (NTRA) on Friday, October 23, 2026, with a Buy rating and a $475 price target, Investing.com reported. The firm built its case on the company's cancer...
    0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
    Please log in to like, share and comment!
© 2026 Net Pals Turkish
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Koşullar Gizlilik Cookies Acceptable Use Contact Us Rehber